ACNP Task Force Report on SSRIs and Suicidal Behavior in Youth

被引:0
|
作者
J John Mann
Graham Emslie
Ross J Baldessarini
William Beardslee
Jan A Fawcett
Frederick K Goodwin
Andrew C Leon
Herbert Y Meltzer
Neal D Ryan
David Shaffer
Karen D Wagner
机构
[1] Columbia University/New York State Psychiatric Institute,
[2] The University of Texas Southwestern Medical Center,undefined
[3] McLean Hospital,undefined
[4] Harvard Medical School/Boston Children's Hospital,undefined
[5] University of New Mexico School of Medicine,undefined
[6] George Washington University Medical Center,undefined
[7] Weill Medical College of Cornell University,undefined
[8] Vanderbilt University Medical Center,undefined
[9] Western Psychiatric Institute & Clinic,undefined
[10] University of Pittsburgh,undefined
[11] University of Texas Medical Branch,undefined
来源
Neuropsychopharmacology | 2006年 / 31卷
关键词
children; adolescents; suicide attempts; suicide; antidepressants; adults;
D O I
暂无
中图分类号
学科分类号
摘要
This Task Force report by the American College of Neuropsychopharmacology evaluates the safety and efficacy of selective serotonin reuptake inhibitor (SSRIs) antidepressants for depressed youth under 18 years. The report was undertaken after regulatory agencies in the United States and United Kingdom raised concerns in 2003 about the possibility that treatment of depression in children and adolescents with SSRIs may increase the risk of suicidal thinking or suicide attempts.
引用
收藏
页码:473 / 492
页数:19
相关论文
共 50 条
  • [1] ACNP task force report on SSRIs and suicidal behavior in youth
    Mann, JJ
    Emslie, G
    Baldessarini, RJ
    Beardslee, W
    Fawcett, JA
    Goodwin, FK
    Leon, AC
    Meltzer, HY
    Ryan, ND
    Shaffer, D
    Wagner, KD
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 (03) : 473 - 492
  • [2] Report by the ACNP Task Force on response and remission in major depressive disorder
    Rush, A. John
    Kraemer, Helena C.
    Sackeim, Harold A.
    Fava, Maurizio
    Trivedi, Madhukar H.
    Frank, Ellen
    Ninan, Philip T.
    Thase, Michael E.
    Gelenberg, Alan J.
    Kupfer, David J.
    Regier, Darrel A.
    Rosenbaum, Jerrold F.
    Ray, Oakley
    Schatzberg, Alan F.
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 (09) : 1841 - 1853
  • [3] Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder
    A John Rush
    Helena C Kraemer
    Harold A Sackeim
    Maurizio Fava
    Madhukar H Trivedi
    Ellen Frank
    Philip T Ninan
    Michael E Thase
    Alan J Gelenberg
    David J Kupfer
    Darrel A Regier
    Jerrold F Rosenbaum
    Oakley Ray
    Alan F Schatzberg
    Neuropsychopharmacology, 2006, 31 : 1841 - 1853
  • [4] Development of Methodological Standards in CNS Pharmacoeconomic Research: Report of an ACNP Task Force
    Robert M A Hirschfeld
    Neuropsychopharmacology, 2001, 25 (5) : 621 - 623
  • [5] Development of methodological standards in CNS pharmacoeconomic research: Report of an ACNP Task Force
    Hirschfeld, RMA
    NEUROPSYCHOPHARMACOLOGY, 2001, 25 (05) : 621 - 623
  • [6] REPORT OF THE TASK-FORCE-ON-CHILDREN-AND-YOUTH
    MOLLER, JH
    ALLEN, HD
    CLARK, EB
    DAJANI, AS
    GOLDEN, A
    HAYMAN, LL
    LAUER, RM
    MARMER, EL
    MCANULTY, JH
    OPARIL, S
    STRAUSS, AW
    TAUBERT, KA
    WAGNER, A
    CIRCULATION, 1993, 88 (05) : 2479 - 2486
  • [7] Learning about the course of suicidal behavior but not about the effects of SSRIs
    Ploederl, Martin
    Hengartner, Michael P.
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (04) : 803 - 803
  • [8] Learning about the course of suicidal behavior but not about the effects of SSRIs
    Martin Plöderl
    Michael P. Hengartner
    Neuropsychopharmacology, 2022, 47 : 803 - 803
  • [10] TASK FORCE REPORT 5 - BEHAVIOR THERAPY IN PSYCHIATRY
    BOND, TC
    AMERICAN JOURNAL OF PSYCHIATRY, 1974, 131 (11): : 1306 - 1306